Published in An Microbiol (Rio J) on January 01, 1968
Moraxella, Acinetobacter, and the Mimeae. Bacteriol Rev (1973) 3.43
Sequences of beta-lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their amino acid sequences with those of other beta-lactamases. Antimicrob Agents Chemother (1996) 5.36
A new plasmidic cefotaximase from patients infected with Salmonella typhimurium. Infection (1992) 4.52
Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis (2000) 4.24
Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol (2001) 4.19
Characterization of beta-lactamase gene blaPER-2, which encodes an extended-spectrum class A beta-lactamase. Antimicrob Agents Chemother (1996) 3.56
Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. Lancet (1996) 3.38
Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin Infect Dis (2001) 3.17
Gene sequence and biochemical characterization of FOX-1 from Klebsiella pneumoniae, a new AmpC-type plasmid-mediated beta-lactamase with two molecular variants. Antimicrob Agents Chemother (1994) 3.09
GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody. J Exp Med (1982) 2.74
Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J Immunol (2001) 2.60
Exocellular components of Paracoccidioides brasiliensis: identification of a specific antigen. Infect Immun (1986) 2.56
Human antibodies against a purified glucosylceramide from Cryptococcus neoformans inhibit cell budding and fungal growth. Infect Immun (2000) 2.12
43-kilodalton glycoprotein from Paracoccidioides brasiliensis: immunochemical reactions with sera from patients with paracoccidioidomycosis, histoplasmosis, or Jorge Lobo's disease. J Clin Microbiol (1991) 2.00
Production of Paracoccidioides brasiliensis exoantigens for immunodiffusion tests. J Clin Microbiol (1988) 1.98
AU cell-surface antigen of human malignant melanoma: solubilization and partial characterization. Proc Natl Acad Sci U S A (1979) 1.86
Human melanoma antigen AH is an autoantigenic ganglioside related to GD2. J Exp Med (1982) 1.85
Highly purified glycosylphosphatidylinositols from Trypanosoma cruzi are potent proinflammatory agents. EMBO J (2000) 1.71
Mapping of the T-cell epitope in the major 43-kilodalton glycoprotein of Paracoccidioides brasiliensis which induces a Th-1 response protective against fungal infection in BALB/c mice. Infect Immun (1998) 1.69
Binding of Paracoccidioides brasiliensis to laminin through surface glycoprotein gp43 leads to enhancement of fungal pathogenesis. Infect Immun (1994) 1.67
Cloning, characterization, and epitope expression of the major diagnostic antigen of Paracoccidioides brasiliensis. J Biol Chem (1996) 1.58
Identification of antigenic polypeptides of Paracoccidioides brasiliensis by immunoblotting. J Med Vet Mycol (1989) 1.54
Cell surface glycoproteins of human tumor cell lines: unusual characteristics of malignant melanoma. J Natl Cancer Inst (1979) 1.51
Comparison of the rhamnomannans from the human pathogen Sporothrix schenckii with those from the Ceratocystis species. Infect Immun (1973) 1.46
Glycosylphosphatidylinositol-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes initiate the synthesis of proinflammatory cytokines by macrophages. J Immunol (1997) 1.39
Isolation and characterization of the localized adherence factor of enteropathogenic Escherichia coli. Infect Immun (1988) 1.33
Mucin-like molecules form a negatively charged coat that protects Trypanosoma cruzi trypomastigotes from killing by human anti-alpha-galactosyl antibodies. J Cell Sci (2000) 1.33
A highly sensitive and specific chemiluminescent enzyme-linked immunosorbent assay for diagnosis of active Trypanosoma cruzi infection. Transfusion (1997) 1.31
Sporothrix schenckii and related species of Ceratocystis. Microbiol Rev (1980) 1.28
Complement-mediated lysis of Trypanosoma cruzi trypomastigotes by human anti-alpha-galactosyl antibodies. J Immunol (1991) 1.28
Fungal morphogenesis and virulence. Med Mycol (2000) 1.26
Immunochemical studies on L-rhamno-D-mannans of Sporothrix schenckii and related fungi by use of rabbit and human antisera. Carbohydr Res (1975) 1.26
Further studies on the rhamnomannans and acidic rhamnomannans of Sporothrix schenckii and Ceratocystis stenoceras. Carbohydr Res (1977) 1.21
Polymorphism of Sporothrix schenckii surface polysaccharides as a function of morphological differentiation. Biochemistry (1976) 1.21
Secretion of the 43 kDa glycoprotein antigen by Paracoccidioides brasiliensis. J Med Vet Mycol (1988) 1.20
Characterization of Fonsecaea pedrosoi melanin. J Gen Microbiol (1991) 1.19
The 43-kDa glycoprotein from the human pathogen Paracoccidioides brasiliensis and its deglycosylated form: excretion and susceptibility to proteolysis. Arch Biochem Biophys (1991) 1.19
DNA-based vaccination against murine paracoccidioidomycosis using the gp43 gene from paracoccidioides brasiliensis. Vaccine (2000) 1.18
Glycoconjugates of Trypanosoma cruzi: a 74 kD antigen of trypomastigotes specifically reacts with lytic anti-alpha-galactosyl antibodies from patients with chronic Chagas disease. J Clin Lab Anal (1993) 1.16
The use of cell-free antigens of Paracoccidioides brasiliensis in serological tests. J Med Vet Mycol (1991) 1.16
Discrimination between Sporothrix schenckii and Ceratocystis stenoceras rhamnomannans by proton and carbon-13 magnetic resonance spectroscopy. Infect Immun (1974) 1.14
Prevalence of extended-spectrum beta-lactamases in South America. Clin Microbiol Infect (2008) 1.12
Monoclonal antibodies against the 43,000 Da glycoprotein from Paracoccidioides brasiliensis modulate laminin-mediated fungal adhesion to epithelial cells and pathogenesis. Hybridoma (1996) 1.11
Structural characterization of the major glycosylphosphatidylinositol membrane-anchored glycoprotein from epimastigote forms of Trypanosoma cruzi Y-strain. J Biol Chem (1995) 1.11
The monoclonal antibody against the major diagnostic antigen of Paracoccidioides brasiliensis mediates immune protection in infected BALB/c mice challenged intratracheally with the fungus. Infect Immun (2008) 1.10
Peptide immunization as an adjuvant to chemotherapy in mice challenged intratracheally with virulent yeast cells of Paracoccidioides brasiliensis. Antimicrob Agents Chemother (2006) 1.10
Pathogenicity of Cryptococcus neoformans: virulence factors and immunological mechanisms. Microbes Infect (1999) 1.10
Deoxyribonucleic acid base composition and hybridization studies on the human pathogen Sporothrix schenckii and Ceratocystis species. Infect Immun (1974) 1.09
Stage-specific glycosphingolipids from amastigote forms of Leishmania (L.) amazonensis. Immunogenicity and role in parasite binding and invasion of macrophages. J Biol Chem (1993) 1.09
Structure of the N-linked oligosaccharide of the main diagnostic antigen of the pathogenic fungus Paracoccidioides brasiliensis. Glycobiology (1996) 1.05
Prophylactic and therapeutic vaccination using dendritic cells primed with peptide 10 derived from the 43-kilodalton glycoprotein of Paracoccidioides brasiliensis. Clin Vaccine Immunol (2011) 1.04
Synthesis and immunological activity of a branched peptide carrying the T-cell epitope of gp43, the major exocellular antigen of Paracoccidioides brasiliensis. Scand J Immunol (2004) 1.03
Thermophilic enteric yeasts. Annu Rev Microbiol (1971) 1.03
A peptidorhamnomannan from the mycelium of Pseudallescheria boydii is a potential diagnostic antigen of this emerging human pathogen. Microbiology (2001) 1.03
O-glycosidically linked N-acetylglucosamine-bound oligosaccharides from glycoproteins of Trypanosoma cruzi. Biochem J (1994) 1.02
Glycoconjugates isolated from Trypanosoma cruzi but not from Leishmania species membranes trigger nitric oxide synthesis as well as microbicidal activity in IFN-gamma-primed macrophages. J Immunol (1997) 1.01
Exocellular proteolytic activity of Paracoccidioides brasiliensis: cleavage of components associated with the basement membrane. Med Mycol (1998) 1.00
Trichomonas vaginalis and Tritrichomonas foetus: expression of chitin at the cell surface. Exp Parasitol (1998) 0.99
Nature of the reactive epitopes in Paracoccidioides brasiliensis polysaccharide antigen. J Med Vet Mycol (1994) 0.98
Identification of genes preferentially expressed in the pathogenic yeast phase of Paracoccidioides brasiliensis, using suppression subtraction hybridization and differential macroarray analysis. Mol Genet Genomics (2004) 0.96
Antibodies as crypts of antiinfective and antitumor peptides. Curr Med Chem (2009) 0.95
Functionally distinct roles for glycosylation of alpha and beta integrin chains in cell-matrix interactions. Proc Natl Acad Sci U S A (1993) 0.94
Crithidia spp.: structural comparison of polysaccharides for taxonomic significance. Exp Parasitol (1982) 0.93
Characterization of an exocellular serine-thiol proteinase activity in Paracoccidioides brasiliensis. Biochem J (1995) 0.93
Sialic acids in fungi: a minireview. Glycoconj J (1999) 0.92
Galactose-containing polysaccharides from the human pathogens Sporothrix schenckii and Ceratocystis stenoceras. Infect Immun (1980) 0.91
Immunochemical and subcellular localization of the 43 kDa glycoprotein antigen of Paracoccidioides brasiliensis with monoclonal antibodies. J Med Vet Mycol (1996) 0.90
Structure of the D-mannan and D-arabino-D-galactan in Crithidia fasciculata: changes in proportion with age of culture. J Protozool (1979) 0.90
Identification of N-acetylneuraminic acid and its 9-O-acetylated derivative on the cell surface of Cryptococcus neoformans: influence on fungal phagocytosis. Infect Immun (1997) 0.90
Modulatory effect of killed Propionibacterium acnes and its purified soluble polysaccharide on peritoneal exudate cells from C57Bl/6 mice: major NKT cell recruitment and increased cytotoxicity. Scand J Immunol (2007) 0.90
Purification of the 43 kDa glycoprotein from exocellular components excreted by Paracoccidioides brasiliensis in liquid culture (TOM medium). J Med Vet Mycol (1991) 0.90
Identification and characterization of protozoan products that trigger the synthesis of IL-12 by inflammatory macrophages. Chem Immunol (1997) 0.88
Paracoccidioidomycosis. J Med Vet Mycol (1992) 0.88
A monoclonal antibody (ST-1) directed to the native heparin chain. Anal Biochem (1992) 0.87
Chemiluminescent immunoassays: discrimination between the reactivities of natural and human patient antibodies with antigens from eukaryotic pathogens, Trypanosoma cruzi and Paracoccidioides brasiliensis. J Clin Lab Anal (1994) 0.87
Synthesis of antimony complexes of yeast mannan and mannan derivatives and their effect on Leishmania-infected macrophages. Biochem J (1993) 0.86
Anti-alpha-galactosyl antibodies in chagasic patients. Possible biological significance. Braz J Med Biol Res (1988) 0.85
Protective, anti-tumor monoclonal antibody recognizes a conformational epitope similar to melibiose at the surface of invasive murine melanoma cells. Hybrid Hybridomics (2002) 0.85
Identification of sialic acids on the cell surface of Candida albicans. Biochim Biophys Acta (2000) 0.85
Plasmid coding for drug resistance and invasion of epithelial cells in enteropathogenic Escherichia coli 0111:H. Microb Pathog (1995) 0.85
GPI-anchored glycoconjugates from Trypanosoma cruzi trypomastigotes are recognized by lytic anti-alpha-galactosyl antibodies isolated from patients with chronic Chagas' disease. Braz J Med Biol Res (1994) 0.84
Gene therapy with interleukin-10 receptor and interleukin-12 induces a protective interferon-γ-dependent response against B16F10-Nex2 melanoma. Cancer Gene Ther (2010) 0.83
Distribution of alpha-galactosyl-containing epitopes on Trypanosoma cruzi trypomastigote and amastigote forms from infected Vero cells detected by Chagasic antibodies. J Eukaryot Microbiol (1994) 0.83
Detection of the basement membrane-degrading proteolytic activity of Paracoccidioides brasiliensis after SDS-PAGE using agarose overlays containing Abz-MKALTLQ-EDDnp. Braz J Med Biol Res (1999) 0.83
Differential inhibitory mechanism of cyclic AMP on TNF-alpha and IL-12 synthesis by macrophages exposed to microbial stimuli. Br J Pharmacol (1999) 0.82
Ingestion of yeast forms of Sporothrix schenckii by mouse peritoneal macrophages. Infect Immun (1983) 0.82
Isolation of Histoplasma capsulatum from bats in the urban area of São Paulo State, Brazil. Epidemiol Infect (2010) 0.82
[Consensus for antimicrobial susceptibility testing for Enterobacteriaceae. Subcommittee on Antimicrobials, SADEBAC (Argentinian Society of Clinical Bacteriology), Argentinian Association of Microbiology]. Rev Argent Microbiol (2005) 0.82
Heterogeneity of the rhamnomannans from one strain of the human pathogen Sporothrix schenckii determined by 13C nuclear magnetic resonance spectroscopy. Infect Immun (1978) 0.82
Effect of environmental factors on Fonsecaea pedrosoi morphogenesis with emphasis on sclerotic cells induced by propranolol. Mycopathologia (1992) 0.82
Anionogenic groups and surface sialoglycoconjugate structures of yeast forms of the human pathogen Paracoccidioides brasiliensis. Microbiology (1998) 0.82
Phosphatase activity on the cell wall of Fonsecaea pedrosoi. Med Mycol (2003) 0.82
Paracoccidioides brasiliensis expresses both glycosylphosphatidylinositol-anchored proteins and a potent phospholipase C. Exp Mycol (1995) 0.82
Experimental paracoccidioidomycosis: alternative therapy with ajoene, compound from Allium sativum, associated with sulfamethoxazole/trimethoprim. Med Mycol (2008) 0.81
alpha6beta1-Integrin, a major cell surface carrier of beta1-6-branched oligosaccharides, mediates migration of EJ-ras-transformed fibroblasts on laminin-1 independently of its glycosylation state. Cancer Res (1996) 0.81
Synthesis of monorhamnosyl L-rhamno-D-mannans by conidia of Sporothrix schenckii. Infect Immun (1978) 0.80
Bacterial resistance to antimicrobial agents in Latin America. The giant is awakening. Infect Dis Clin North Am (2000) 0.80
Cross-reactive polysaccharides from Trypanosoma cruzi and fungi (especially Dactylium dendroides). J Protozool (1986) 0.80